- Home
- RGC vs VIGL Comparison
RGC vs VIGL Comparison
Compare RGC & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- VIGL
- Stock Information
- Founded
- RGC 2014
- VIGL 2020
- Country
- RGC Hong Kong
- VIGL United States
- Employees
- RGC N/A
- VIGL N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- RGC Health Care
- VIGL Health Care
- Exchange
- RGC Nasdaq
- VIGL Nasdaq
- Market Cap
- RGC 38.6B
- VIGL 134.9M
- IPO Year
- RGC 2021
- VIGL 2022
- Fundamental
- Price
- RGC $14.50
- VIGL $8.07
- Analyst Decision
- RGC
- VIGL Buy
- Analyst Count
- RGC 0
- VIGL 7
- Target Price
- RGC N/A
- VIGL $8.00
- AVG Volume (30 Days)
- RGC 2.5M
- VIGL 830.8K
- Earning Date
- RGC 06-30-2025
- VIGL 08-12-2025
- Dividend Yield
- RGC N/A
- VIGL N/A
- EPS Growth
- RGC N/A
- VIGL N/A
- EPS
- RGC N/A
- VIGL N/A
- Revenue
- RGC N/A
- VIGL N/A
- Revenue This Year
- RGC N/A
- VIGL N/A
- Revenue Next Year
- RGC N/A
- VIGL N/A
- P/E Ratio
- RGC N/A
- VIGL N/A
- Revenue Growth
- RGC N/A
- VIGL N/A
- 52 Week Low
- RGC $0.08
- VIGL $1.31
- 52 Week High
- RGC $83.60
- VIGL $8.10
- Technical
- Relative Strength Index (RSI)
- RGC 45.47
- VIGL 88.16
- Support Level
- RGC $13.54
- VIGL $8.03
- Resistance Level
- RGC $16.68
- VIGL $8.10
- Average True Range (ATR)
- RGC 4.11
- VIGL 0.03
- MACD
- RGC -0.87
- VIGL -0.10
- Stochastic Oscillator
- RGC 24.79
- VIGL 87.56
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.